(CHRD)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
This stock has a consensus price target of $150.59 based on the ratings of 18 analysts. The high is $211.00 and the low is $97.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 97 | $ 150.59 | $ 211 |
| O’zgarish | -33.26% | 3.61% | 45.17% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-27 | 15.58% | Morgan Stanley | $114 → $168 | Upgrades | Equal-Weight → Overweight |
| 2026-03-24 | 16.27% | Truist Securities | $169 | Initiates Coverage On | Buy |
| 2026-03-16 | -6.43% | Wells Fargo | $109 → $136 | Maintains | Overweight |
| 2026-03-12 | 30.72% | Piper Sandler | $158 → $190 | Maintains | Overweight |
| 2026-03-06 | -17.44% | Citigroup | $97 → $120 | Maintains | Neutral |